Related references
Note: Only part of the references are listed.Potential of Host Defense Peptide Prodrugs as Neutrophil Elastase-Dependent Anti-Infective Agents for Cystic Fibrosis
Eanna Forde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Effects of PEGylation on Membrane and Lipopolysaccharide Interactions of Host Defense Peptides
Shalini Singh et al.
BIOMACROMOLECULES (2014)
Controlled Systemic Release of Therapeutic Peptides from PEGylated Prodrugs by Serum Proteases
Friederike Inga Nollmann et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials
Luis Maiz et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Sensitization of gram-negative bacteria by targeting the membrane potential
Keren Goldberg et al.
FASEB JOURNAL (2013)
Pharmacology of polymyxins: new insights into an 'old' class of antibiotics
Tony Velkov et al.
FUTURE MICROBIOLOGY (2013)
Optimization of Anti-Pseudomonal Antibiotics for Cystic Fibrosis Pulmonary Exacerbations: IV. Colistimethate Sodium
David C. Young et al.
PEDIATRIC PULMONOLOGY (2013)
Emerging Themes and Therapeutic Prospects for Anti-Infective Peptides
Nannette Y. Yount et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Pegylation of Antimicrobial Peptides Maintains the Active Peptide Conformation, Model Membrane Interactions, and Antimicrobial Activity while Improving Lung Tissue Biocompatibility following Airway Delivery
Christopher J. Morris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
A comprehensive summary of LL-37, the factotum human cathelicidin peptide
Dieter Vandamme et al.
CELLULAR IMMUNOLOGY (2012)
Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis
Peter Greally et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections
Nicole J. Afacan et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Beyond conventional antibiotics for the future treatment of methicillin-resistant Staphylococcus aureus infections: two novel alternatives
Deirdre Fitzgerald-Hughes et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2012)
Designing antimicrobial peptides: form follows function
Christopher D. Fjell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides
Christopher J. Arnusch et al.
PLOS ONE (2012)
β-Lactam-host defence peptide conjugates as antibiotic prodrug candidates targeting resistant bacteria
Stephane Desgranges et al.
RSC ADVANCES (2012)
Targeted antimicrobial peptides
Marc Devocelle
FRONTIERS IN IMMUNOLOGY (2012)
Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications
Shashwat S. Banerjee et al.
JOURNAL OF DRUG DELIVERY (2012)
In Vitro Activities of Synthetic Host Defense Propeptides Processed by Neutrophil Elastase against Cystic Fibrosis Pathogens
Stephane Desgranges et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches
Andrea Giuliani et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation
Seong-Cheol Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Synthesis of Mutual Azo Prodrugs of Anti-inflammatory Agents and Peptides Facilitated by α-Aminoisobutyric Acid
David A. Kennedy et al.
JOURNAL OF ORGANIC CHEMISTRY (2011)
Enhancement of the cancer targeting specificity of buforin lib by fusion with an anionic peptide via a matrix metalloproteinases-cleavable linker
Ju Hye Jang et al.
PEPTIDES (2011)
Interaction between amphiphilic peptides and phospholipid membranes
Adam A. Stromstedt et al.
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2010)
Design and activity of a 'dual-targeted' antimicrobial peptide
Jian He et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture
Michael R. Franzman et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Host Defense Peptides as Effector Molecules of the Innate Immune Response: A Sledgehammer for Drug Resistance?
Lars Steinstraesser et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)
Boosting Antimicrobial Peptides by Hydrophobic Oligopeptide End Tags
Artur Schmidtchen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline
Gudmundur Bergsson et al.
JOURNAL OF IMMUNOLOGY (2009)
Modification of Antimicrobial Peptide with Low Molar Mass Poly(ethylene glycol)
Genghui Zhang et al.
JOURNAL OF BIOCHEMISTRY (2008)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Action mechanism of PEGylated magainin 2 analogue peptide
Yuichi Imura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Action mechanism of tachyplesin I and effects of PEGylation
Yuichi Imura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Antimicrobial peptides: an overview of a promising class of therapeutics
Andrea Giuliani et al.
CENTRAL EUROPEAN JOURNAL OF BIOLOGY (2007)
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Robert E. W. Hancock et al.
NATURE BIOTECHNOLOGY (2006)
Targeted killing of Streptococcus mutans by a pheromone-guided smart antimicrobial peptide
Randal Eckert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Andreas Peschel et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Design of a peptibody consisting of the antimicrobial peptide dhvar5 and a llama variable heavy-chain antibody fragment
A. Szynol et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
PEG-doxorubicin conjugates: Influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity
FM Veronese et al.
BIOCONJUGATE CHEMISTRY (2005)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis
XQ Qiu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
T Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Opinion - Can innate immunity be enhanced to treat microbial infections?
BB Finlay et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Inactivation of human β-defensins 2, and 3 by elastolytic cathepsins
CC Taggart et al.
JOURNAL OF IMMUNOLOGY (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
HPMA copolymers with pH-controlled release of doxorubicin -: In vitro cytotoxicity and in vivo antitumor activity
K Ulbrich et al.
JOURNAL OF CONTROLLED RELEASE (2003)
An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria
XQ Qiu et al.
NATURE BIOTECHNOLOGY (2003)
Polyacetal-doxorubicin conjugates designed for pH-dependent degradation
R Tomlinson et al.
BIOCONJUGATE CHEMISTRY (2003)
Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7
K Sadler et al.
BIOCHEMISTRY (2002)
Antimicrobial peptides from animals: focus on invertebrates
J Vizioli et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
Antimicrobial peptides of multicellular organisms
M Zasloff
NATURE (2002)
Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3
OE Sorensen et al.
BLOOD (2001)
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers
LJ Zhang et al.
BIOCHEMISTRY (2000)
Share Paper
